Theratechnologies to Announce First Quarter 2025 Financial Results and Provide Business Update
Theratechnologies (NASDAQ: THTX) has scheduled its first quarter 2025 financial results announcement and business update for April 9, 2025, at 8:30 a.m. ET. The conference call will feature key executives including CEO Paul Lévesque, CFO Philippe Dubuc, Chief Medical Officer Christian Marsolais, and Global Commercial Officer John Leasure.
The management team will present the Q1 2025 results for the period ended February 28 and will be available for a Q&A session following their prepared remarks. The presentation will be accessible via webcast and telephone conference, with replay available until April 16, 2025.
Theratechnologies (NASDAQ: THTX) ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 e un aggiornamento aziendale per il 9 aprile 2025, alle 8:30 ET. La conferenza telefonica vedrà la partecipazione di importanti dirigenti tra cui il CEO Paul Lévesque, il CFO Philippe Dubuc, il Chief Medical Officer Christian Marsolais e il Global Commercial Officer John Leasure.
Il team di gestione presenterà i risultati del Q1 2025 per il periodo conclusosi il 28 febbraio e sarà disponibile per una sessione di domande e risposte dopo le loro dichiarazioni preparate. La presentazione sarà accessibile tramite webcast e conferenza telefonica, con una registrazione disponibile fino al 16 aprile 2025.
Theratechnologies (NASDAQ: THTX) ha programado el anuncio de los resultados financieros del primer trimestre de 2025 y una actualización empresarial para el 9 de abril de 2025, a las 8:30 a.m. ET. La conferencia telefónica contará con la participación de ejecutivos clave, incluido el CEO Paul Lévesque, el CFO Philippe Dubuc, el Chief Medical Officer Christian Marsolais y el Global Commercial Officer John Leasure.
El equipo de dirección presentará los resultados del Q1 2025 para el período que finalizó el 28 de febrero y estará disponible para una sesión de preguntas y respuestas después de sus comentarios preparados. La presentación será accesible a través de webcast y conferencia telefónica, con una repetición disponible hasta el 16 de abril de 2025.
Theratechnologies (NASDAQ: THTX)는 2025년 4월 9일 오전 8시 30분 ET에 2025년 1분기 재무 결과 발표 및 사업 업데이트를 예정하고 있습니다. 이번 컨퍼런스 콜에는 CEO Paul Lévesque, CFO Philippe Dubuc, Chief Medical Officer Christian Marsolais, Global Commercial Officer John Leasure 등 주요 경영진이 참여할 예정입니다.
경영팀은 2월 28일 종료된 기간에 대한 2025년 1분기 결과를 발표하고, 준비된 발언 후에는 질문 및 답변 세션에 참석할 것입니다. 발표는 웹캐스트와 전화 회의를 통해 접근 가능하며, 2025년 4월 16일까지 재생이 가능합니다.
Theratechnologies (NASDAQ: THTX) a programmé l'annonce des résultats financiers du premier trimestre 2025 et une mise à jour de l'entreprise pour le 9 avril 2025 à 8h30 ET. L'appel conférence mettra en vedette des cadres clés, y compris le PDG Paul Lévesque, le CFO Philippe Dubuc, le Chief Medical Officer Christian Marsolais et le Global Commercial Officer John Leasure.
L'équipe de direction présentera les résultats du T1 2025 pour la période se terminant le 28 février et sera disponible pour une session de questions-réponses après leurs remarques préparées. La présentation sera accessible via webcast et conférence téléphonique, avec un replay disponible jusqu'au 16 avril 2025.
Theratechnologies (NASDAQ: THTX) hat die Bekanntgabe der finanziellen Ergebnisse für das erste Quartal 2025 und ein Unternehmensupdate für den 9. April 2025 um 8:30 Uhr ET geplant. Die Telefonkonferenz wird wichtige Führungskräfte umfassen, darunter CEO Paul Lévesque, CFO Philippe Dubuc, Chief Medical Officer Christian Marsolais und Global Commercial Officer John Leasure.
Das Managementteam wird die Ergebnisse des Q1 2025 für den Zeitraum bis zum 28. Februar präsentieren und steht nach ihren vorbereiteten Ausführungen für eine Frage- und Antwortsession zur Verfügung. Die Präsentation wird über Webcast und Telefonkonferenz zugänglich sein, mit einer Wiederholung, die bis zum 16. April 2025 verfügbar ist.
- None.
- None.
MONTREAL, April 03, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the Company will report financial results and provide a business update for its first quarter 2025 ended February 28 on Wednesday, April 9, 2025, at 8:30 a.m. ET.
The call will be hosted by Paul Lévesque, President and Chief Executive Officer, who will be joined by other members of the management team, including Philippe Dubuc, Senior Vice President and Chief Financial Officer, Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer and John Leasure, Global Commercial Officer. They will be available to answer questions from participants following prepared remarks.
Participants are encouraged to join the call at least ten minutes in advance to secure access. Conference call dial-in and replay information can be found below.
| CONFERENCE CALL INFORMATION | |
| Conference Call Date | April 9, 2025 |
| Conference Call Time | 8:30 a.m. ET |
| Webcast Link | https://edge.media-server.com/mmc/p/coipg2gb |
| Dial in | 1-877-513-4119 (toll free) or 1-412-902-6615 (international) |
| Access Code | 2419339 |
| CONFERENCE CALL REPLAY | |
| Toll Free | 1-877-344-7529 (US) / 1-855-669-9658 (Canada) |
| International Toll | 1-412-317-0088 |
| Replay Access Code | 5058651 |
| Replay End Date | April 16, 2025 |
| To access the replay using an international dial-in number, please select this link: https://services.choruscall.com/ccforms/replay.html | |
An archived webcast will also be available on the Company’s Investor Relations website under ‘Past Events’.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X.
Contacts:
Investor inquiries:
Joanne Choi
Senior Director, Investor Relations
jchoi@theratech.com
1-551-261-0401
Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
1-514-336-7800
FAQ
When will Theratechnologies (THTX) release Q1 2025 earnings?
How can investors access THTX's Q1 2025 earnings call?
Who will present during Theratechnologies' Q1 2025 earnings call?
Until when will THTX's Q1 2025 earnings call replay be available?
